ISHP Research Fellowship
According to its statutes, the International Society for the History of Pharmacy (ISHP) promotes research, teaching and publication in pharmaceutical history. Based on this, ISHP will continue to support pharmaceutical history research proposals of international relevance and is again awarding a grant for 2500 Euro in total.
The grant is primarily, but not exclusively, intended for academic projects. Proposals for the 2023/24 ISHP Fellowship grant must be sent by email, in English language to the ISHP General Secretary by the August 31, 2023.The proposal must include:
• a detailed description of the research project which is usually but not necessarily done at an academic institution
• a detailed discussion of the project’s relevance in terms of internationality
• a curriculum vitae of the applicant
• a confirmation that the applicant is a member of ISHP issued by his national organization
• a list of former research projects and publications of the applicant
• a letter of recommendation from a senior academic teacher
• a detailed list of expenses expected (i.e. costs for traveling, obtaining literature etc.)
The proposals will be judged by a fellowship committee comprised of the ISHP President, the ISHP General Secretary and three distinguished scientists in the field of pharmaceutical history, nominated by the Select Executive Committee.
A successful applicant is obliged to describe the project during the ISHP General Assembly or another opportunity during the International Congress for the History of Pharmacy held in the year 2024 in Belgrade. After the project has been completed, ISHP needs to be informed in detail about the results (e.g. by sending a comprehensive report, reprints of publications) until the project is completed, and interim reports have to be sent to ISHP every year in December.
ISHP General Secretary
List of Fellowship recipients
Kayoko Shimada-Takaura, Japan: The exploration of the suites of crude drug specimens collected around early 20th century reflecting the region specific ‘medicinal culture’.
Florian Eidam-Weber, Germany: Ethnopharmaceutical research by the Austrian tibetologist and ethnologist René Nebesky-Wojkowitz (1923–1959).
Dr. Tünde Ambrus, Czech Republic: Historical sources and cultural heritage of pharmaceutical activities of the Hospitaller Order of St. John of God in the Central European Region.
Samaneh Soleymani, Iran: Classification of Persian and Arabic Pharmaceutical books and treatises in Islamic civilization (8th to 18th century CE)
Markus Maxim, Germany: Transmission of medical-pharmaceutical knowledge between East Africa and Europe in the context of the Bethel Missions in the 20th century.
Yohko Natsume, Japan: Research on the development of pharmaceutical theory in ancient India; the Bower Manuscript.
Paulina Oszajca, Poland: Theriac and its’ derivatives in the Early Modern Europe society (16th – 18th century); a comparative study.
Jelena Manojlovic, Serbia: The art of pharmaceutical care. Influence of the Habsburg Monarchy and the Ottoman Empire on the skills and doctrine of pharmaceutical care in countries of South-Eastern Europe in the period from the 16th to the 18th century; a comparative study.
Juris Salaks, Latvia: The operations of F. Hofmann-La Roche in Russia from 1896 until 1920
Dimitrios Koutroumpas: Galen’s Pharmacology: Simple medicines and their theoretical model according to Galen
Joan E. Taylor, United Kingdom: The Essenes and Dead Sea Pharmacology
Maki Umemura, Japan: History of the post-war Japanese pharmaceutical industry
Svetlana Hautala, Italy: Communication of the pharmaceutical knowledge in Hellenistic Greece: the case of itinerant vendors of remedies
Ute Mauch, Germany: Alexander Hispanus and his medical compendium – critical appraisal of the ‘Melleus liquor physicae artis’ with a historical depiction of the pharmaceutical plants contained therein
Sabine Anagnostou, Germany: Missionary pharmacy – Christian mission – international drug transfer – change of materiae medicae (16.–18.c.)
Andreea Nitulescu, Doina Draganescu: Relationship between pharmaceutical legislation from several European countries after the First World War – the pathway to the present pharmaceutical legislation in the European Union.